bDMARD: biologic disease-modifying antirheumatic drug; CTLA4-Ig: CTLA4–immunoglobulin fusion protein; csDMARD: conventional synthetic disease-modifying antirheumatic drug; ETN: etanercept; GC: glucocorticoid; IBD: inflammatory bowel disease; JAKi: Janus kinase inhibitor; MTX: methotrexate; PDE4i: phosphodiesterase 4 inhibitor; TNFi: TNF inhibitor.
* A conditional recommendation based on data from abstracts only.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟